Page last updated: 2024-08-16

terbutaline and hydralazine

terbutaline has been researched along with hydralazine in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's0 (0.00)18.2507
2000's7 (63.64)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Leenen, FH; Reeves, RA1
Cordasco, EM1
Johansson, K; Lind, L; Pettersson, K1

Reviews

1 review(s) available for terbutaline and hydralazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for terbutaline and hydralazine

ArticleYear
Beta-receptor-mediated increase in venous return in humans.
    Canadian journal of physiology and pharmacology, 1987, Volume: 65, Issue:8

    Topics: Adult; Atenolol; Clinical Trials as Topic; Double-Blind Method; Echocardiography; Epinephrine; Female; Heart; Heart Ventricles; Humans; Hydralazine; Isoproterenol; Male; Propranolol; Random Allocation; Receptors, Adrenergic, beta; Terbutaline; Veins; Ventricular Function

1987

Other Studies

9 other study(ies) available for terbutaline and hydralazine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Pulmonary vascular disease--overview.
    Angiology, 1983, Volume: 34, Issue:10

    Topics: Angiography; Heparin; Humans; Hydralazine; Hypertension, Pulmonary; Lung; Lung Diseases, Obstructive; Lymphangiomyoma; Medroxyprogesterone; Oxygen Inhalation Therapy; Phlebography; Pulmonary Artery; Pulmonary Embolism; Radionuclide Imaging; Terbutaline; Thrombophlebitis; Urokinase-Type Plasminogen Activator

1983
Analysis of endothelium-dependent vasodilation by use of the radial artery pulse wave obtained by applanation tonometry.
    Clinical physiology and functional imaging, 2003, Volume: 23, Issue:1

    Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Brachial Artery; Diastole; Drug Combinations; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hydralazine; Injections, Intra-Arterial; Nitric Oxide; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Pulse; Radial Artery; Terbutaline; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2003